Page 166 - Williams Hematology ( PDFDrive )

140 Part III: Epochal Hematology Chapter 9: Hematology in Older Persons 141

263. Grubeck-Loebenstein B, Wick G: The aging of the immune system. Adv Immunol 282. Bernstein E, Kaye D, Abrutyn E, et al: Immune response to influenza vaccination in a
80:243–284, 2002. large healthy elderly population. Vaccine 17(1):82–94, 1999.
264. Vallejo AN: Age-dependent alterations of the T cell repertoire and functional diversity 283. Gross PA, Quinnan GV Jr, Weksler ME, et al: Relation of chronic disease and immune
of T cells of the aged. Immunol Res 36(1–3):221–228, 2006. response to influenza vaccine in the elderly. Vaccine 7(4):303–308, 1989.
265. Mascarucci P, Taub D, Saccani S, et al: Age-related changes in cytokine production by 284. McElhaney JE, Meneilly GS, Lechelt KE, et al: Antibody response to whole-virus and
leukocytes in rhesus monkeys. Aging (Milano) 13(2):85–94, 2001. split-virus influenza vaccines in successful ageing. Vaccine 11(10):1055–1060, 1993.
266. Mascarucci P, Taub D, Saccani S, et al: Cytokine responses in young and old rhesus 285. Murasko DM, Bernstein ED, Gardner EM, et al: Role of humoral and cell-mediated
monkeys: Effect of caloric restriction. J Interferon Cytokine Res 22(5):565–571, 2002. immunity in protection from influenza disease after immunization of healthy elderly.
267. Daynes RA, Araneo BA, Ershler WB, et al: Altered regulation of IL-6 production with Exp Gerontol 2002;37(2–3):427–439, 1998.
normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone 286. Muszkat M, Friedman G, Dannenberg HD, et al: Response to influenza vaccination
and its sulfated derivative. J Immunol 150(12):5219–5230, 1993. in community and in nursing home residing elderly: Relation to clinical factors. Exp
268. Fagiolo U, Cossarizza A, Scala E, et al: Increased cytokine production in mononuclear Gerontol 38(10):1199–1203, 2003.
cells of healthy elderly people. Eur J Immunol 23(9):2375–2378, 1993. 287. Yamamoto K, Takeshita K, Shimokawa T, et al: Plasminogen activator inhibitor-1 is a
269. Kania DM, Binkley N, Checovich M, et al: Elevated plasma levels of interleukin-6 major stress-regulated gene: Implications for stress-induced thrombosis in aged indi-
in postmenopausal women do not correlate with bone density. J Am Geriatr Soc viduals. Proc Natl Acad Sci U S A 99(2):890–895, 2002.
43(3):236–239, 1995. 288. Tracy RP, Bovill EG, Yanez D, et al: Fibrinogen and factor VIII, but not factor VII, are
270. Straub RH, Konecna L, Hrach S, et al: Serum dehydroepiandrosterone (DHEA) and associated with measures of subclinical cardiovascular disease in the elderly. Results
DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA from The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 15(9):1269–1279,
inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between 1995.
endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83(6): 289. Harris TB, Ferrucci L, Tracy RP, et al: Associations of elevated interleukin-6 and C-re-
2012–2017, 1998. active protein levels with mortality in the elderly. Am J Med 106(5):506–512, 1999.
271. Young DG, Skibinski G, Mason JI, James K: The influence of age and gender on serum 290. Taaffe DR, Harris TB, Ferrucci L, et al: Cross-sectional and prospective relationships of
dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and interleukin-6 and C-reactive protein with physical performance in elderly persons: Mac-
transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors. Arthur studies of successful aging. J Gerontol A Biol Sci Med Sci 55(12):M709–M715,
Clin Exp Immunol 117(3):476–481, 1999. 2000.
272. Chorinchath BB, Kong LY, Mao L, McCallum RE: Age-associated differences in TNF- 291. Yaffe K, Lindquist K, Penninx BW, et al: Inflammatory markers and cognition in well-
alpha and nitric oxide production in endotoxic mice. J Immunol 156(4):1525–1530, 1996. functioning African-American and white elders. Neurology 61(1):76–80, 2003.
273. O’Mahony L, Holland J, Jackson J, et al: Quantitative intracellular cytokine measure- 292. Abbatecola AM, Ferrucci L, Grella R, et al: Diverse effect of inflammatory markers
ment: Age-related changes in proinflammatory cytokine production. Clin Exp Immunol on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc
113(2):213–219, 1998. 52(3):399–404, 2004.
274. Roubenoff R, Harris TB, Abad LW, et al: Monocyte cytokine production in an elderly 293. Cesari M, Leeuwenburgh C, Lauretani F, et al: Frailty syndrome and skeletal muscle:
population: Effect of age and inflammation. J Gerontol A Biol Sci Med Sci 53(1): Results from the Invecchiare in Chianti study. Am J Clin Nutr 83(5):1142–1148, 2006.
M20–M26, 1998. 294. Pai JK, Pischon T, Ma J, et al: Inflammatory markers and the risk of coronary heart
275. Wu WC, Schifftner TL, Henderson WG, et al: Preoperative hematocrit levels and disease in men and women. N Engl J Med 351(25):2599–2610, 2004.
postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 295. Shlipak MG, Fried LF, Crump C, et al: Elevations of inflammatory and procoagulant
297(22):2481–2488, 2007. biomarkers in elderly persons with renal insufficiency. Circulation 107(1):87–92, 2003.
276. Kollman C, Howe CW, Anasetti C, et al: Donor characteristics as risk factors in recip- 296. Ding C, Parameswaran V, Udayan R, et al: Circulating levels of inflammatory markers
ients after transplantation of bone marrow from unrelated donors: The effect of donor predict change in bone mineral density and resorption in older adults: A longitudinal
age. Blood 98(7):2043–2051, 2001. study. J Clin Endocrinol Metab 93(5):1952–1958, 2008.
277. Penninx BW, Guralnik JM, Onder G, et al: Anemia and decline in physical performance 297. Spranger J, Kroke A, Mohlig M, et al: Inflammatory cytokines and the risk to develop
among older persons. Am J Med 115(2):104–110, 2003. type 2 diabetes: Results of the prospective population-based European Prospective
278. Penninx BW, Kritchevsky SB, Newman AB, et al: Inflammatory markers and incident Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52(3):812–817,
mobility limitation in the elderly. J Am Geriatr Soc 52(7):1105–1113, 2004. 2003.
279. Penninx BW, Pahor M, Cesari M, et al: Anemia is associated with disability and 298. Finch CE, Landfield PW: Neuroendocrine and autonomic functions in aging mammals,
decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc in Handbook of the Biology of Aging, edited by CE Finch, EL Schenider, pp 567–595. Van
52(5):719–724, 2004. Nostrand Reinhold, New York, 1985.
280. Penninx BW, Pluijm SM, Lips P, et al: Late-life anemia is associated with increased risk 299. Ferrucci L, Guralnik JM, Bandinelli S, et al: Unexplained anaemia in older persons is
of recurrent falls. J Am Geriatr Soc 53(12):2106–2111, 2005. characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J
281. Ezekowitz JA, McAlister FA, Armstrong PW: Anemia is common in heart failure and Haematol 136(6):849–855, 2007.
is associated with poor outcomes: Insights from a cohort of 12 065 patients with new- 300. Denny SD, Kuchibhatla MN, Cohen HJ: Impact of anemia on mortality, cognition, and
onset heart failure. Circulation 107(2):223–225, 2003. function in community-dwelling elderly. Am J Med 119(4):327–334, 2006.

Kaushansky_chapter 09_p0129-0142.indd 141 17/09/15 6:16 pm